GrantRover ↗

← Alle Förderungen

Defense Health Agency Contracting Activity - DHACA · USA

DoW Rare Cancers Resource and Community Development Award

Offen

Defense Health Agency Contracting Activity - DHACA plant 5 Förderungen bei einem Gesamtbudget von 5,6 Mio. $. Die Einreichungsfrist endet am 18. November 2026. Antragsberechtigte Gruppen laut Quelle: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility".

Frist
18. November 2026 (in 3 Tagen)
Fördersumme
≈ 1,12 Mio. $ pro Förderung (Schätzung: Gesamtbudget ÷ 5)
Gesamtbudget
5,6 Mio. $
Förderquote
Kein Pflicht-Eigenanteil angegeben; Förderquote nicht angegeben
Gesamtbudget
5,6 Mio. $
Erwartete Förderungen
5
Eigenanteil
Nicht erforderlich
Wahrscheinliche Antragstellende
Unternehmen, KMU / Start-ups, Gemeinnützige, Hochschulen & Forschung, Öffentliche Stellen, Einzelpersonen Aus Quellkategorien oder Programmregeln; maßgeblich ist die Ausschreibung.
Fördergeber
Defense Health Agency Contracting Activity - DHACA
Referenz
HT942526RCRPRCDA
Assistance Listing (USA)
12.420 Military Medical Research and Development
Zuletzt geprüft
13. November 2026

Offizielle Ausschreibung öffnen ↗ Frist zum Kalender hinzufügen

Die offiziellen Beschreibungen sind in der Sprache des Fördergebers (meist Englisch); Zusammenfassung und Eckdaten auf dieser Seite sind auf Deutsch.

Über diese Ausschreibung

Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Resource and Community Development Award (RCDA) supports the development of research resources and clinical or preclinical datasets that will advance the field of rare cancers research and ultimately improve outcomes for individuals with rare cancers. Research supporting this funding opportunity should fill one of the following major gaps:

• Lack of research and clinical resources, including patient tissues, cell and tumor models.

• Lack of communication and dissemination strategies within scientific and patient communities for sharing rare cancers research and clinical findings.

• Lack of infrastructure for sharing data and other resources.

• Lack of therapeutics and mechanistic research to inform treatment development.

Distinctive Features:

• Documentation of plans for engagement and partnerships with Patient Advocates throughout the life cycle of the research study from development of the research question through execution of the study.

Vollständigen Text lesen

• Community building and enhancement are key components.

• A description of the dissemination and sustainability of the platform for scientific and/or clinical and patient community is required.

• Preliminary data are not required but may be included to address feasibility.

Wer kann sich bewerben?

Antragstellerkategorien sind nur ein Ausgangspunkt. Über die Antragsberechtigung entscheidet die offizielle Ausschreibung.

Themen

Science and Technology and other Research and Development

So bewerben Sie sich

  1. Read the full notice of funding opportunity (NOFO) linked from the official page: eligibility, cost sharing and evaluation criteria.
  2. Make sure your organisation has an active SAM.gov registration and Unique Entity ID (UEI); registration can take several weeks.
  3. Register with Grants.gov and set up a Workspace for this opportunity, with the right roles for your organisation.
  4. Prepare the required forms, narrative, budget and attachments exactly as the NOFO specifies.
  5. Submit before the deadline and keep the tracking number. Check for amendments before you submit.

From the call text

Who can apply
Not stated in the call text we hold — check the official page
Company stage
Not stated in the call text we hold — check the official page
Single applicant or consortium
Not stated in the call text we hold — check the official page
Where applicants must be based
Not stated in the call text we hold — check the official page
Where to apply
Not stated in the call text we hold — check the official page

Kontakt

JoAnn Martin · help@eBRAP.org · 301-619-2594

Offizielle Quellen

Offizielle Ausschreibungsseite

Die Angaben auf dieser Seite stammen aus der offiziellen Quelle und wurden zuletzt am 13. November 2026 geprüft. Maßgeblich sind immer die Unterlagen des Fördergebers einschließlich späterer Änderungen.

Weitere Ausschreibungen: Defense Health Agency Contracting Activity - DHACA

Defense Health Agency Contracting Activity - DHACA USA

DoW Joint Warfighter Medical, Military Medical Research and Development Award

HT942526JWMRPMMRDA

Summary: The fiscal year 2026 (FY26) Joint Warfighter Medical Research Program (JWMRP) Military Medical Research and Development Award (MMRDA) mechanism is intended to fu…

Defense Health Agency Contracting Activity - DHACA USA

DoW Breast Cancer, Breakthrough Award Levels 1 and 2

HT942526BCRPBTA122

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make…

Defense Health Agency Contracting Activity - DHACA USA

DoW Breast Cancer, Clinical Research Extension Award

HT942526BCRPCREA2

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Clinical Research Extension Award supports research that extends the data collection, follow-up…

Defense Health Agency Contracting Activity - DHACA USA

DOW Combat Readiness – Medical Research Program Translational Research Award

HT942526CRRPTRA

Summary: The fiscal year 2026 (FY26) Combat Readiness – Medical Research Program (CRRP) Translational Research Award (TRA) supports hypothesis-driven innovative, high-imp…

Defense Health Agency Contracting Activity - DHACA USA

DoW Orthopaedic, Applied Research Award

HT942526ORPARA

Summary: The Orthopaedic Research Program (ORP) Applied Research Award (ARA) seeks applied research applications focused on advancing optimal treatment and restoration of…